149 related articles for article (PubMed ID: 37210001)
21. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
22. Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
Kanwal F; Singal AG
Gastroenterology; 2019 Jul; 157(1):54-64. PubMed ID: 30986389
[TBL] [Abstract][Full Text] [Related]
23. Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance.
Jang S; Jin YJ; Lee JW; Kwon D; Yu JH
Medicine (Baltimore); 2023 Aug; 102(32):e34637. PubMed ID: 37565915
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.
Fujiwara N; Friedman SL; Goossens N; Hoshida Y
J Hepatol; 2018 Mar; 68(3):526-549. PubMed ID: 28989095
[TBL] [Abstract][Full Text] [Related]
25. Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand.
Schauer C; van Rijnsoever M; Gane E
J Viral Hepat; 2019 Dec; 26(12):1372-1376. PubMed ID: 31323163
[TBL] [Abstract][Full Text] [Related]
26. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement.
Stefanini B; Tonnini M; Serio I; Renzulli M; Tovoli F
Expert Rev Anticancer Ther; 2022 Apr; 22(4):371-381. PubMed ID: 35263211
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease.
Seif El Dahan K; Daher D; Singal AG
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S207-S219. PubMed ID: 36103899
[TBL] [Abstract][Full Text] [Related]
28. Early detection of hepatocellular carcinoma: roadmap for improvement.
Melendez-Torres J; Singal AG
Expert Rev Anticancer Ther; 2022 Jun; 22(6):621-632. PubMed ID: 35514249
[TBL] [Abstract][Full Text] [Related]
29. Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma.
Kondo T; Koroki K; Kanzaki H; Kobayashi K; Kiyono S; Nakamura M; Kanogawa N; Saito T; Ogasawara S; Ooka Y; Nakamoto S; Chiba T; Arai M; Kato J; Kuboki S; Ohtsuka M; Kato N
PLoS One; 2022; 17(1):e0261619. PubMed ID: 35085277
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology.
Huang DQ; Singal AG; Kanwal F; Lampertico P; Buti M; Sirlin CB; Nguyen MH; Loomba R
Nat Rev Gastroenterol Hepatol; 2023 Dec; 20(12):797-809. PubMed ID: 37537332
[TBL] [Abstract][Full Text] [Related]
31. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis.
Li Y; Li J; He T; Song Y; Wu J; Wang B
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553600
[TBL] [Abstract][Full Text] [Related]
32. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Silveira MG; Suzuki A; Lindor KD
Hepatology; 2008 Oct; 48(4):1149-56. PubMed ID: 18785621
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.
Wan DW; Tzimas D; Smith JA; Kim S; Araujo J; David R; Lobach I; Sarpel U
Am J Gastroenterol; 2011 Nov; 106(11):1994-2000. PubMed ID: 21912436
[TBL] [Abstract][Full Text] [Related]
34. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
35. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Yang H; Bae SH; Nam H; Lee HL; Lee SW; Yoo SH; Song MJ; Kwon JH; Nam SW; Choi JY; Yoon SK; Jang JW
J Hepatol; 2022 Sep; 77(3):632-641. PubMed ID: 35398462
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
37. HCC surveillance after SVR in patients with F3/F4 fibrosis.
Ioannou GN
J Hepatol; 2021 Feb; 74(2):458-465. PubMed ID: 33303216
[TBL] [Abstract][Full Text] [Related]
38. Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis.
Nazareth S; Leembruggen N; Tuma R; Chen SL; Rao S; Kontorinis N; Cheng W
Int J Nurs Pract; 2016 Jun; 22 Suppl 2():3-11. PubMed ID: 27476494
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P
J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727
[TBL] [Abstract][Full Text] [Related]
40. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.
Flemming JA; Yang JD; Vittinghoff E; Kim WR; Terrault NA
Cancer; 2014 Nov; 120(22):3485-93. PubMed ID: 25042049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]